Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback